{"id":56924,"date":"2024-02-27T17:14:41","date_gmt":"2024-02-27T17:14:41","guid":{"rendered":"https:\/\/medsname.com\/progynova\/"},"modified":"2026-09-07T05:44:27","modified_gmt":"2026-09-07T05:44:27","slug":"progynova","status":"publish","type":"product","link":"https:\/\/medsbase.com\/progynova\/","title":{"rendered":"Progynova"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udca1 Quick Answer<\/strong><\/p>\n<p style=\"margin: 0;\"><strong>Progynova<\/strong> is an <strong>oral systemic estrogen<\/strong> (estradiol valerate) used for menopausal hormone therapy \u2014 treating hot flushes, night sweats, vaginal dryness, and bone-density loss. <strong>Women with an intact uterus must combine estrogen with a progestin<\/strong> (unopposed estrogen raises endometrial cancer risk ~8\u201315\u00d7). Short-term use (1\u20135 years) at the lowest effective dose is the modern standard; long-term risks include breast cancer, VTE, and stroke (Women&#8217;s Health Initiative data).<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>What you get with MedsBase:<\/strong> WHO-GMP certified manufacturer \u00b7 Discreet packaging \u00b7 Worldwide shipping \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/reviews\/\">customer reviews<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Every order is covered by our <a href=\"https:\/\/medsbase.com\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 if your parcel does not arrive within 20 business days, we reship it.<\/p>\n<h3>Why order from MedsBase<\/h3>\n<p>Every MedsBase order ships from a WHO-GMP certified manufacturer in plain, fully discreet packaging \u2014 nothing on the outside identifies the contents or the pharmacy. Card payments run through a regulated crypto on-ramp; the statement descriptor on your bank record is the processor name (a regulated card-payment processor) \u2014 never \u201cMedsBase\u201d or anything pharmacy-related. Crypto payments via Plisio stay fully anonymous. Every parcel is covered by our <a href=\"https:\/\/medsbase.com\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>.<\/p>\n<h2><strong>What Is Progynova?<\/strong><\/h2>\n<p>Progynova is a branded generic of <strong>estradiol valerate<\/strong>, a systemic oral estrogen used as <strong>menopausal hormone therapy (MHT \/ HRT)<\/strong>. Estrogen replaces the hormone lost after natural or surgical menopause, relieving the symptom cluster known as the <strong>climacteric syndrome<\/strong>.<\/p>\n<p>Strengths: <strong>1 mg, 2 mg (oral tablets, 28 or 56-tablet packs)<\/strong>. Manufactured by Bayer.<\/p>\n<h2><strong>Clinical Uses<\/strong><\/h2>\n<ul>\n<li><strong>Vasomotor symptoms<\/strong> (hot flushes, night sweats) \u2014 most effective treatment available, ~75\u201390% reduction in trials.<\/li>\n<li><strong>Genitourinary syndrome of menopause<\/strong> \u2014 vaginal dryness, dyspareunia, recurrent UTIs. Vaginal estrogen is preferred for symptoms limited to the genitourinary tract.<\/li>\n<li><strong>Postmenopausal osteoporosis prevention<\/strong> \u2014 reduces fracture risk by ~30\u201350% with extended use. No longer first-line when bisphosphonates or denosumab are indicated.<\/li>\n<li><strong>Premature ovarian insufficiency (POI)<\/strong> \u2014 physiological replacement in women under 40 with premature menopause.<\/li>\n<li><strong>Female-to-male \u2192 female gender-affirming hormone therapy<\/strong> (off-label on this site; specialist-guided).<\/li>\n<\/ul>\n<h2><strong>Critical: Progestin Opposition<\/strong><\/h2>\n<p><strong>If you have a uterus, you must take estrogen combined with a progestin<\/strong>. Unopposed estrogen stimulates endometrial proliferation, raising endometrial cancer risk ~8\u201315\u00d7. Options:<\/p>\n<ul>\n<li><strong>Combined continuous<\/strong> \u2014 estrogen daily + progestin daily (no withdrawal bleed after 3\u20136 months)<\/li>\n<li><strong>Sequential (cyclic)<\/strong> \u2014 estrogen daily + progestin 10\u201314 days per month (withdrawal bleed each cycle)<\/li>\n<li><strong>Mirena IUD<\/strong> \u2014 delivers local progestin to the endometrium; allows estrogen monotherapy elsewhere<\/li>\n<\/ul>\n<p><strong>Women who have had a hysterectomy<\/strong> can take estrogen alone without a progestin. See our progesterone products: <a href=\"https:\/\/medsbase.com\/endogest\/\">Endogest<\/a>, <a href=\"https:\/\/medsbase.com\/gestheal\/\">Gestheal<\/a>, <a href=\"https:\/\/medsbase.com\/susten-capsule\/\">Susten Capsule<\/a>.<\/p>\n<h2><strong>How to Take<\/strong><\/h2>\n<ol>\n<li>Take one tablet once daily, at roughly the same time each day, with water. With or without food.<\/li>\n<li>Start at the lowest effective dose \u2014 typically 0.3 mg conjugated estrogens or 0.5\u20131 mg estradiol \u2014 and titrate up only if symptoms are incompletely controlled after 4\u20136 weeks.<\/li>\n<li>If cycle-regimen is used, the progestin is taken for the last 10\u201314 days of each 28-day cycle; withdrawal bleeding is expected.<\/li>\n<li>For continuous-combined regimen, take both hormones daily; irregular bleeding may occur for the first 3\u20136 months.<\/li>\n<li><strong>Use the lowest effective dose for the shortest effective duration.<\/strong> Review annually with a clinician. Most guidelines recommend discontinuation after 3\u20135 years.<\/li>\n<\/ol>\n<h2><strong>Risks and Safety (WHI and Follow-Up Evidence)<\/strong><\/h2>\n<p>The Women&#8217;s Health Initiative (WHI) trials redefined HRT risk understanding. Key findings per 10,000 women per year of combined estrogen-progestin HRT:<\/p>\n<ul>\n<li><strong>Breast cancer:<\/strong> +8 cases (with progestin); estrogen alone did not raise breast cancer risk over ~7 years in WHI<\/li>\n<li><strong>Stroke:<\/strong> +8 strokes<\/li>\n<li><strong>VTE (DVT\/PE):<\/strong> +18 events \u2014 highest risk in first year; oral &gt; transdermal<\/li>\n<li><strong>Coronary heart disease:<\/strong> +7 events in older HRT starters (60+), but possibly protective in younger starters (&lt;60)<\/li>\n<li><strong>Hip fracture:<\/strong> \u22125 (protective)<\/li>\n<li><strong>Colorectal cancer:<\/strong> \u22126 (protective, combined HRT)<\/li>\n<li><strong>Endometrial cancer:<\/strong> +1 (lower with progestin opposition)<\/li>\n<\/ul>\n<p>Risk-benefit is most favourable in <strong>women under 60 with severe symptoms and no contraindications<\/strong>. Transdermal estrogen (patch, gel) may reduce VTE risk vs oral.<\/p>\n<h2><strong>Side Effects<\/strong><\/h2>\n<p><strong>Common:<\/strong> breast tenderness, nausea, headache, fluid retention, mood changes, vaginal bleeding (normal in first 3\u20136 months of continuous-combined regimen).<\/p>\n<p><strong>Less common:<\/strong> melasma, gallstones, contact-lens intolerance, libido changes.<\/p>\n<p><strong>Serious (rare) \u2014 seek urgent care:<\/strong> chest pain, shortness of breath, severe leg swelling (VTE\/PE), sudden severe headache with neurological changes (stroke), breast lump, yellowing of skin\/eyes (liver problem), heavy or prolonged vaginal bleeding.<\/p>\n<h2><strong>Who Should Not Take Progynova<\/strong><\/h2>\n<ul>\n<li>Current, suspected, or history of breast cancer or estrogen-dependent cancer<\/li>\n<li>Current or history of VTE (DVT, PE), thrombophilia, active thromboembolic disease<\/li>\n<li>History of stroke, TIA, or recent MI<\/li>\n<li>Active liver disease or cholestatic jaundice history (with previous pregnancy or estrogen use)<\/li>\n<li>Undiagnosed vaginal bleeding<\/li>\n<li>Known pregnancy<\/li>\n<li>Endometrial hyperplasia (investigate first)<\/li>\n<li>Known hypersensitivity<\/li>\n<\/ul>\n<h2><strong>Drug Interactions<\/strong><\/h2>\n<ul>\n<li><strong>Enzyme inducers<\/strong> (rifampicin, phenytoin, carbamazepine, St John&#8217;s Wort) reduce estrogen levels \u2014 higher-dose estrogen or alternative route may be needed.<\/li>\n<li><strong>Thyroxine (levothyroxine)<\/strong>: estrogen raises thyroid-binding globulin, may increase thyroxine requirement.<\/li>\n<li><strong>Warfarin<\/strong>: estrogen reduces warfarin effect slightly; monitor INR.<\/li>\n<li><strong>Grapefruit juice<\/strong>: may raise estrogen levels modestly.<\/li>\n<\/ul>\n<h2><strong>Storage<\/strong><\/h2>\n<p>Store at room temperature (15\u201325 \u00b0C \/ 59\u201377 \u00b0F), away from moisture and direct light. Keep in original packaging. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Frequently Asked Questions<\/h2>\n<h3 class=\"wp-block-heading\">When should I start HRT?<\/h3>\n<p>Modern guidelines suggest starting HRT within 10 years of menopause onset or before age 60 (&#8220;window of opportunity&#8221;) for best cardiovascular safety profile. Starting HRT after age 65 has a less favourable risk-benefit ratio unless severe symptoms persist.<\/p>\n<h3 class=\"wp-block-heading\">Do I need a progestin if I have a uterus?<\/h3>\n<p>Yes \u2014 always. Unopposed estrogen raises endometrial cancer risk 8\u201315\u00d7. Take estrogen with micronized progesterone (endogest, gestheal, etc.), dydrogesterone, medroxyprogesterone, or a Mirena IUD.<\/p>\n<h3 class=\"wp-block-heading\">How long can I stay on HRT?<\/h3>\n<p>Modern practice: lowest effective dose, shortest duration \u2014 typically 3\u20135 years, reviewed annually. Extended use is appropriate for severe symptoms, premature menopause, or osteoporosis; discussed on an individual basis.<\/p>\n<h3 class=\"wp-block-heading\">Is HRT safer as a patch or gel than a pill?<\/h3>\n<p>Transdermal estrogen has a lower VTE risk (no first-pass hepatic effect) and is preferred for women with VTE risk factors, migraine, or hepatic concerns. Oral is convenient and well-studied but carries slightly higher thrombotic risk.<\/p>\n<h3 class=\"wp-block-heading\">What about bioidentical hormones?<\/h3>\n<p>Estradiol (the molecule in Progynova) is bioidentical. Conjugated estrogens (Premarin) are not strictly bioidentical. Micronized progesterone is bioidentical. &#8220;Compounded bioidentical&#8221; custom-mixed products at non-standard doses have no proven advantage and often lack quality control \u2014 most gynaecology societies do not recommend them.<\/p>\n<h3 class=\"wp-block-heading\">Will HRT cause breast cancer?<\/h3>\n<p>Risk depends on type and duration. Estrogen-only (women without uterus): no clear breast cancer risk increase over ~7 years in WHI. Combined estrogen-progestin: ~+8 cases per 10,000 women per year. Risk returns to baseline within 2\u20135 years of stopping.<\/p>\n<h3 class=\"wp-block-heading\">Will HRT help my mood or sleep?<\/h3>\n<p>Often \u2014 especially if vasomotor symptoms are disrupting sleep or causing irritability. HRT is not an antidepressant; severe mood symptoms may need separate treatment.<\/p>\n<h3 class=\"wp-block-heading\">Can HRT cause weight gain?<\/h3>\n<p>Weight gain is more commonly linked to the perimenopausal transition itself (shifting body composition, declining estrogen) than HRT. Modern low-dose HRT is typically weight-neutral.<\/p>\n<h3 class=\"wp-block-heading\">What should I do if I have vaginal bleeding on HRT?<\/h3>\n<p>Expected for 3\u20136 months on continuous-combined HRT. Withdrawal bleeding is expected on cyclic HRT. <strong>Unexpected or prolonged bleeding<\/strong> beyond 6 months needs clinical review (endometrial biopsy or ultrasound) to rule out endometrial hyperplasia or cancer.<\/p>\n<h3 class=\"wp-block-heading\">What about non-hormonal alternatives?<\/h3>\n<p>For vasomotor symptoms: SSRIs\/SNRIs (paroxetine, venlafaxine), gabapentin, clonidine, cognitive-behavioural therapy, fezolinetant (newer neurokinin-3 antagonist). For genitourinary symptoms: vaginal moisturisers, lubricants, ospemifene. Discuss with a clinician.<\/p>\n<h3 class=\"wp-block-heading\">Related Hormone &amp; Women&#8217;s Health Products<\/h3>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/premarin\/\">Premarin (Conjugated Estrogens)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/premarin-cream\/\">Premarin Cream (Vaginal Estrogen)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/endogest\/\">Endogest (Progesterone 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/gestoford\/\">Gestoford (Progesterone 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/gestheal\/\">Gestheal (Progesterone 200 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/susten-capsule\/\">Susten Capsule (Progesterone)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/susten-injection\/\">Susten Injection (Progesterone)<\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 14px 20px; margin: 16px 0; border-radius: 4px; font-size: 0.9em;\">\n<p style=\"margin: 0;\"><strong>\u2695\ufe0f Medical Disclaimer:<\/strong> Information is educational and does not replace medical advice. Hormone therapies carry specific risks (breast cancer, VTE, stroke, endometrial cancer if unopposed estrogen) \u2014 consult a clinician before starting, stopping, or changing any hormone medication. Individual risk\u2013benefit depends on personal and family medical history.<\/p>\n<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Related Alternatives<\/h3>\n<p>Other products in <strong>Women&#8217;s Health<\/strong> that customers also view:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/candifem-vaginal-cream\/\">Candifem Vaginal Cream<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/yasmin\/\">Yasmin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cb-lin\/\">Cb-Lin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/gestheal\/\">Gestheal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/danogen\/\">Danogen<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u2705 Hormone Replacement Therapy<br \/>\n\u2705 Manages Menopausal Symptoms<br \/>\n\u2705 Prevents Osteoporosis<br \/>\n\u2705 Prescribed by Gynecologists<br \/>\n\u2705 Improves Quality of Life<\/p>\n<p><strong>Progynova<\/strong> contains <strong>Estradiol<\/strong>.<\/p>\n","protected":false},"featured_media":56925,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3519,3502],"product_tag":[3527,4201],"class_list":{"0":"post-56924","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-hormone-replacement-therapy-hrt-medication-for-menopause","8":"product_cat-womens-health","9":"product_tag-estradiol","10":"product_tag-progynova","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product\/56924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/comments?post=56924"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/media\/56925"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/media?parent=56924"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_brand?post=56924"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_cat?post=56924"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_tag?post=56924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}